SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-326046
Filing Date
2017-10-31
Accepted
2017-10-31 09:01:47
Documents
32
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d335642d10q.htm 10-Q 162529
2 EX-31.1 d335642dex311.htm EX-31.1 6354
3 EX-31.2 d335642dex312.htm EX-31.2 6357
4 EX-32.1 d335642dex321.htm EX-32.1 2878
5 EX-32.2 d335642dex322.htm EX-32.2 2881
  Complete submission text file 0001193125-17-326046.txt   996415

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hppi-20170930.xml EX-101.INS 97585
7 XBRL TAXONOMY EXTENSION SCHEMA hppi-20170930.xsd EX-101.SCH 16519
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20170930_cal.xml EX-101.CAL 21683
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20170930_def.xml EX-101.DEF 42795
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20170930_lab.xml EX-101.LAB 128270
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20170930_pre.xml EX-101.PRE 83378
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 171164181
SIC: 8731 Services-Commercial Physical & Biological Research